Conceptio
›
Archive
›
HAL (France)
HAL (France)
open access
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401
Reinhard Dummer et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Digital capacity and the conditional effectiveness of green bonds in global climate finance markets
#1015828
Synthesizability: The Open Question in Digital MOF Discovery
#1015829
Une introduction à la théologie médio-platonicienne : le Didaskalikos d’Alcinoos
#1015830
Jean-Noël Jouzel, Giovanni Prete, L’agriculture empoisonnée. Le long combat des victimes des pesticides
#1015831
The Value of Structuring Literary Data and Vocabulary : Computational Analysis of Generative Mechanisms in the Shījīng
#1015832
Record
· ID 145067
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.